Vaginal Biome Science

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Vaginal Biome Science sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).

9 total trials none currently recruiting 7 completed early-phase tilt top decile by trial count

Vaginal Biome Science: 9 sponsored US clinical trials, none currently recruiting.

Vaginal Biome Science sponsors 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Bacterial Vaginosis, with 1 trials.

Top-decile sponsor footprint

Vaginal Biome Science ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Indexed trials (enrollment closed)

9 total, page 1 of 1

COMPLETED NA

Vaginal Care System for Menopausal Women With Urinary Tract Infections

NCT05573334
COMPLETED NA

Effect of Flourish HEC Vaginal Care System on BV Recurrence and the Vaginal Microbiome

NCT05701722
TERMINATED NA

Effects of Flourish HEC Vaginal Care System on Birth-Related Pelvic Floor Disorders

NCT05665569
COMPLETED NA

Effects of Flourish HEC on Localized Provoked Vulvodynia

NCT05478746
COMPLETED NA

Effects of Flourish on Recurrent Urinary Tract Infection

NCT05397782
TERMINATED Phase 1

Effects of Flourish HEC and BioGenesis to Improve Conception

NCT05390606
COMPLETED NA

Flourish Vaginal Care System to Establish Neovaginal Microbiome

NCT05372770
COMPLETED NA

Flourish HEC to Prevent Recurrence of BV

NCT05386147
COMPLETED

Clinical Trial to Survey Results of Flourish Vaginal Care System for Recurrent Bacterial Vaginosis

NCT03734523

Phase Distribution

PhaseTrial count
Phase 1 1

Therapeutic Areas

Bacterial Vaginosis 1

How the Vaginal Biome Science early-phase archive is shaped

9 indexed studies, none listed as recruiting (0% open); 7 completed (78%).

Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).

Top condition: Bacterial Vaginosis (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Vaginal Biome Science: archived-pipeline peers nationwide

Peers matched on 9 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Vaginal Biome Science sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40%50% Total trials Recruiting share Vaginal Biome Science4D Molecular Therapeutics9 Meters BiopharmaAadi BioscienceAblynx, a Sanofi company10xBio22nd Century Group23andMe3-C Institute for Social Development
Vaginal Biome Science sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Vaginal Biome Science sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 9 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Vaginal Biome Science page

9 registered trials is a research-attention snapshot, not an endorsement of Vaginal Biome Science or any single study.

  • None of Vaginal Biome Science's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Bacterial Vaginosis is the condition Vaginal Biome Science studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Bacterial Vaginosis trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Vaginal Biome Science pipeline card: 9 registered trials from official public datasets.Report a data error.